Evaluating the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Combinations of Monoclonal Antibodies PGT121, PGDM1400, 10-1074, and VRC07-523LS Administered Via Intravenous Infusion in Healthy, HIV-uninfected Adult Participants
Clinical trial NCT03928821 · COMPLETED
Trial details
- NCT number
- NCT03928821
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-17
- Primary completion
- 2021-03-25
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.